Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salvianolate injection for NSTEMI-ACS patients undergoing PCI
ChiCTR1800016992Phase 4Recruiting
- Sponsor
- Huashan Hospital
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of salvianolate in acute coronary syndrome (ACS), unstable angina and Myocardial Infarction (MI) (2 arms), sponsored by Huashan Hospital. Primary endpoint: Major adverse cardiovascular events. Started Oct 2016; status: recruiting.
02
Drugs
salvianolate
03
Conditions
acute coronary syndrome (ACS)unstable anginaMyocardial Infarction (MI)
Beyond the preview
Go deeper on ChiCTR1800016992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016992.